Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days
Saturday Opinion: IAM deputy editor Angela Morris confronts the claim that 2022 US patent grants may indicate American industry is slipping in the global innovation race
Nanoco Group pockets $90 million after attorneys and a litigation finance firm are paid
A string of deals announced during December and the beginning of January send a very clear message to policymakers and regulators
12 January 2023
The court rejected Juno Therapeutics’ appeal, despite claims of similarity with Amgen v Sanofi dispute
11 January 2023
R&D collaboration entails risk and it is therefore vital for companies to start thinking about the best strategies to adopt
11 January 2023
Former company Head of IP Strategy worked as the facilitator for agreements that cover a range of technologies
11 January 2023
Cell phone purchasers can pursue claims that Qualcomm closed off the market via exclusive contracts, yet the attack has failed against its “no licence, no chip” policy
10 January 2023
Sales of drug earnings streams is an increasingly popular means of monetising life sciences innovations
10 January 2023
Eeva Hakoranta reflects on holdout, policy moves and the benefits of arbitration as we move into the new year
10 January 2023
Docket Navigator data indicates patent filings decreased the most in Delaware and West Texas – but Eastern Texas got a slight bump
09 January 2023
Patent litigation settlements face increasingly dangerous antitrust pitfalls
09 January 2023
Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days
08 January 2023
Unlock unlimited access to all IAM content
